Posts

Rewind Therapeutics raises additional financing for oral remyelination program

on

Lilly expands Gate Bioscience deal with more than $870 million in potential payments

on

Candel Therapeutics to Present Two Posters at SITC 2026

on

RAG-18 shows early target engagement in a three-person DMD cohort

on

Vaxcyte shares surge after positive Phase 3 vaccine results

on

FDA extends review of Novo’s hemophilia A drug over factory remediation

on

Genentech licenses Alector’s preclinical Parkinson’s candidate for $100 million upfront

on

CSL and Alentis strike up to US$1.6 billion drug-development deal

on

Recent pharma deals: AstraZeneca backs ivonescimab

on

Bayer plans $2.2 billion Ohio pharmaceutical manufacturing campus

on

Possible match: NTx raises $47.5M for RNA manufacturing

on

Asia pharma deal roundup: AZ backs ivonescimab, Novo licenses Hengrui’s GLP-1/GIP drug, Merck targets KRAS

on

AstraZeneca backs Summit with $2 billion stake and cancer-drug collaboration

on